Biomarcadores de imagen multimodal
Publicaciones destacadas
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Gine, Eva; de la Cruz, Fatima; Jimenez Ubieto, Ana; Lopez Jimenez, Javier; Martin Garcia-Sancho, Alejandro;(...)Garcia Sanz, Ramon; Nadeu, Ferran; Bea, Silvia; Campo, Elias; Lopez-Guillermo, Armando.Referencia:Journal Of Clinical Oncology 2022.
-
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [<sup>18</sup>F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125
Glickman, A; Carreras-Diéguez, N; Pahisa, J; Fusté, P; Del Pino, M;(...)Romero, I; Gaba, L; Fernández-Galán, E; Carrasco, JL; Gil-Ibáñez, B.Referencia:European Radiology 2022.
-
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines
Canals, J; Navarro, A; Díaz, T; Acosta-Plasencia, M; Cros-Font, C;Han, B; He, YY; Monzó, M; Vila, C; Canals, JM.Referencia:Journal Of Experimental & Clinical Cancer Research 2022.
-
Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery
Vollmer, I; Martínez, D; Sánchez-Lorente, D; Paredes, P; Sánchez-Izquierdo, N;Casanueva-Eliceiry, S; Romero-Zayas, I; Vidal-Sicart, S; Boada, M; Guirao, A.Referencia:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients
de Aledo-Castillo, JMG; Casanueva-Eliceiry, S; Fuster, D; Paredes, P; Soler-Perromat, A;(...)Reguart, N; Puig-Butillé, JA; Viñolas, N; Reyes, R; Pastor, V.Referencia:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer
Vidal-Sicart, S; Rioja, ME; Prieto, A; Goñi, E; Gómez, I;Albala, MD; Lumbreras, L; León, LF; Gómez, JR; Campos, F.Referencia:Journal Of Nuclear Medicine 2021.
-
PET/CT Integrated With CT Colonography in Preoperative Obstructive Colorectal Cancer by Incomplete Optical Colonoscopy A Prospective Study
Sanchez-Izquierdo, Nuria; Pages, Mario; Mayoral, Maria; Rubello, Domenico; Colletti, Patrick M.;Campos, Francisco; Romero, Inmaculada; Casanueva, Sebastian; Fritsch, Andrea; Fuster, David;.Referencia:Clinical Nuclear Medicine 2020.
-
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma
Sánchez-Izquierdo, N; Perlaza, P; Mayoral, M; Casanueva, S; Fuster, D;(...)Rios, J; Rubello, D; Colletti, PM; Fernández-Esparrach, G; Ginés, A.Referencia:Clinical Nuclear Medicine 2020.
-
Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients
Riquelme-Mc Loughlin, Constanza; Podlipnik, Sebastian; Bosch-Amate, Xavier; Riera-Monroig, Jose; Barreiro, Alicia;(...)Sanchez, Marcelo; Vidal-Sicart, Sergi; Carrera, Cristina; Malvehy, Josep; Puig, Susana.Referencia:Journal Of The American Academy Of Dermatology 2019.
-
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G;(...)Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D .Referencia:Clinical Nuclear Medicine 2018.